Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...
2h
News-Medical.Net on MSNFGFR2 identified as key driver in KRAS-mutated pancreatic cancer progressionPrecancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...
In a recent study, precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS ...
Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...
Marathon effort aims to give ‘more than hope’ to people with pancreatic cancer - Pancreatic Cancer UK is the TCS London ...
Researchers have developed an inexpensive blood test that they say can detect pancreatic cancer — even in its early stages.
Explore more
Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...
12d
Live Science on MSNSimple blood tests could be the future of cancer diagnosisBlood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer ...
Joan Vassos, “Star Trek” Team, Days of our Lives’ Martha Madison & Eric Martsolf, Eric Idle, Lisa Swayze, and Judge [...] ...
New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, ...
Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results